Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
Status:
Not yet recruiting
Trial end date:
2022-06-09
Target enrollment:
Participant gender:
Summary
Clinical, control, double-blind, randomized experimentation with N-acetylcysteine and
bromhexine for COVID-19.
Phase:
Phase 3
Details
Lead Sponsor:
Universidade Federal do Ceara
Collaborators:
Ceará Health Secretariat - SESA Central Laboratory of Public Health of Ceara - LACEN-CE Health Surveillance Secretariat - SVS Leonardo da Vinci Hospital - HLV Municipal Health Secretary - SMS-Fortaleza Paulista School of Medicine-EPM, UNIFESP São José Hospital for Infectious Diseases - HSJ